Shufro Rose & CO LLC Sanofi Transaction History

Shufro Rose & CO LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	SELL	$38.86 - $48.55 $15,544 - $19,420	-400 Reduced 7.43%	4,980 $0
Q4 2021 Jan 27, 2022	SELL	$47.07 - $52.35 $18,828 - $20,940	-400 Reduced 6.92%	5,380 $270,000
Q3 2021 Nov 05, 2021	SELL	$47.89 - $53.12 $9,578 - $10,624	-200 Reduced 3.34%	5,780 $279,000
Q1 2021 Apr 28, 2021	SELL	$45.46 - $50.51 $9,092 - $10,102	-200 Reduced 3.24%	5,980 $296,000
Q2 2020 Aug 06, 2020	SELL	$42.91 - $52.5 $4,291 - $5,250	-100 Reduced 1.59%	6,180 $315,000
Q1 2019 May 03, 2019	SELL	$40.83 - $45.43 $8,982 - $9,994	-220 Reduced 3.38%	6,280 $278,000
Q4 2018 Feb 01, 2019	SELL	$41.48 - $45.59 $4,148 - $4,559	-100 Reduced 1.52%	6,500 $282,000
Q3 2018 Oct 26, 2018	SELL	$40.0 - $44.84 $24,000 - $26,904	-600 Reduced 8.33%	6,600 $295,000
Q3 2017 Nov 13, 2017	BUY	$47.04 - $50.34 $338,688 - $362,448	7,200	7,200 $358,000

823

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $125B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Shufro Rose & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Shufro Rose & CO LLC with notifications on news.